Aranesp is the trade name for Darbepoetin alfa, a synthetic version of erythropoietin, which stimulates the production of red blood cells. Aranesp has been used since its approval by the U.S. Food and Drug Administration (FDA) in 2001 to treat patients with anemia, as well as chronic renal failure. It has been frequently prescribed to individuals suffering anemia as a byproduct of chemotherapy.
The FDA has required black box warnings on all sales of Darbepoetin alfa in the United States, citing a number of potential adverse health risks, including:
- Myocardial infarction, or heart attack, as well as congestive heart failure
Hypertension (high blood pressure), with increased risk of stroke
- Venous thromboembolism
- Thrombosis of vascular access
- Tumor progression or recurrence
If you experienced side effects after being prescribed Aranesp, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
What Is a Misdemeanor? Is a Misdemeanor a Crime? What Are the Consequences of a Misdemeanor Convicti…Read More 24 Dec 2020, Thursday
How Easy Would It Be to Abolish the Electoral College?
What Would Be Required to Change How Presidents Are Elected? The unique method by which the United S…Read More 03 Dec 2020, Thursday
The 25th Amendment to the United States Constitution Is in the News
The Constitutional Process for Replacing a President Who Lacks Capacity to Serve The United States C…Read More 15 Oct 2020, Thursday